Company Analysis

Evogene Ltd (EVGN)

Nasdaq: EVGN · Agricultural Chemicals · Rehovot, IL · filing with the SEC since 2013
Grade4.0
◀ Past 3.5● Present 4.2▶ Future 4.4
2 est.

Who runs Evogene Ltd

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Haviv Ofer
President and CEO. First filing Mar 2026, latest Mar 18, 2026, 0 filings in all.
Officers reporting now
5
of 10 people with a filing in the last fifteen months
Directors reporting now
5
10 people on the record since 2026
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Tarcic GabiChief Development OfficerMar 2026Aug 26, 2026none
Ravzin PolinaVP FinanceApr 2026Apr 9, 2026none
Haviv OferPresident and CEOMar 2026Mar 18, 2026none
Eldad YaronChief Financial OfficerMar 2026Mar 18, 2026none
Zhidkov IliaChief Technology OfficerMar 2026Mar 18, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Falk Dan MichaeldirectorMar 2026Sep 30, 2026none
Nimrodi NirdirectorMar 2026Sep 30, 2026none
Percy Adrian JohndirectorMar 2026Sep 30, 2026none
Recanati LeondirectorMar 2026Sep 30, 2026none
Firon SaritdirectorMar 2026Mar 18, 2026none

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton EVGN · research, not advice